Jean-Antoine Ribeil, PhD

Publications

• Published on 11/22/2023

  Pollock G, Negre O, Ribeil JA. Gene-addition/editing therapy in sickle cell disease. Presse Med. 2023 Dec; 52(4):104214. PMID: 38000628.

  Read at: PubMed
• Published on 6/13/2023

  Hara Y, Lemgart VT, Halland N, Mahdaviani K, Ribeil JA, Lessard S, Hicks A, Light DR. SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells. Blood Adv. 2023 Jun 13; 7(11):2317-2323. PMID: 36696461.

  Read at: PubMed
• Published on 5/12/2023

  Ribeil JA, Pollock G, Frangoul H, Steinberg MH. An integrated therapeutic approach to sickle cell disease management beyond infancy. Am J Hematol. 2023 Jul; 98(7):1087-1096. PMID: 37170801.

  Read at: PubMed
• Published on 10/10/2022

  Kanter J, Thompson AA, Pierciey FJ, Hsieh M, Uchida N, Leboulch P, Schmidt M, Bonner M, Guo R, Miller A, Ribeil JA, Davidson D, Asmal M, Walters MC, Tisdale JF. Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study. Am J Hematol. 2023 Jan; 98(1):11-22. PMID: 36161320.

  Read at: PubMed
• Published on 1/24/2022

  Magrin E, Semeraro M, Hebert N, Joseph L, Magnani A, Chalumeau A, Gabrion A, Roudaut C, Marouene J, Lefrere F, Diana JS, Denis A, Neven B, Funck-Brentano I, Negre O, Renolleau S, Brousse V, Kiger L, Touzot F, Poirot C, Bourget P, El Nemer W, Blanche S, Tréluyer JM, Asmal M, Walls C, Beuzard Y, Schmidt M, Hacein-Bey-Abina S, Asnafi V, Guichard I, Poirée M, Monpoux F, Touraine P, Brouzes C, de Montalembert M, Payen E, Six E, Ribeil JA, Miccio A, Bartolucci P, Leboulch P, Cavazzana M. Long-term outcomes of lentiviral gene therapy for the ß-hemoglobinopathies: the HGB-205 trial. Nat Med. 2022 01; 28(1):81-88. PMID: 35075288.

  Read at: PubMed
• Published on 12/12/2021

  Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, Aygun B, Kasow KA, Pierciey FJ, Bonner M, Miller A, Zhang X, Lynch J, Kim D, Ribeil JA, Asmal M, Goyal S, Thompson AA, Tisdale JF. Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. N Engl J Med. 2022 02 17; 386(7):617-628. PMID: 34898139.

  Read at: PubMed
• Published on 10/20/2021

  Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, Lucchini MJ, Machin J, Nimubona S, Ribeil JA, Galacteros F, Cannas G, Hot A. Pregnancy outcome in women with transfused beta-thalassemia in France. Ann Hematol. 2022 Feb; 101(2):289-296. PMID: 34668980.

  Read at: PubMed
• Published on 10/19/2021

  Ribeil JA. Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms? Am J Hematol. 2022 01 01; 97(1):4-6. PMID: 34626435.

  Read at: PubMed
• Published on 3/24/2021

  Chauvet M, Chhuon C, Lipecka J, Dechavanne S, Dechavanne C, Lohezic M, Ortalli M, Pineau D, Ribeil JA, Manceau S, Le Van Kim C, Luty AJF, Migot-Nabias F, Azouzi S, Guerrera IC, Merckx A. Sickle Cell Trait Modulates the Proteome and Phosphoproteome of Plasmodium falciparum-Infected Erythrocytes. Front Cell Infect Microbiol. 2021; 11:637604. PMID: 33842387.

  Read at: PubMed
• Published on 2/11/2021

  Joseph L, Jean C, Manceau S, Chalas C, Arnaud C, Kamdem A, Pondarré C, Habibi A, Bernaudin F, Allali S, de Montalembert M, Boutonnat-Faucher B, Arlet JB, Koehl B, Cavazzana M, Ribeil JA, Lionnet F, Berthaut I, Brousse V. Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease. Blood. 2021 02 11; 137(6):826-829. PMID: 32976551.

  Read at: PubMed

View 60 more publications: View full profile at BUMC